Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX4032 in Patients With Solid Tumors

NCT00405587 is registered in ClinicalTrials.gov with Plexxikon as lead sponsor.

NCT NCT00405587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00405587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX4032 in Patients With Solid Tumors
Lead sponsor
Plexxikon
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2006
Completion date
February 29, 2016
Enrollment
109 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal carcinoma, malignant melanoma